Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model
在生物发光小鼠模型中,口服2-氨基嘧啶罗贝尼定类似物(NCL195)可显著降低金黄色葡萄球菌感染,并与亚抑制浓度的粘菌素联合使用降低大肠杆菌感染。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00424-23
Nguyen, Hang Thi; Venter, Henrietta; Woolford, Lucy; Young, Kelly A; McCluskey, Adam; Garg, Sanjay; Sapula, Sylvia S; Page, Stephen W; Ogunniyi, Abiodun David; Trott, Darren J